Emmis Acquisition Corp. (EMIS) Stock Price & Analysis
Emmis Acquisition Corp. (EMIS) rose 0.00% to USD 10.19 as of July 25, 2026 at 05:30 UTC, according to Nexqual real-time market data.
EMIS last closed at USD 10.19; the session ranged USD 10.19–10.19 on volume of 7 shares. Market capitalization is $160.76M, with a 52-week range of USD 9.9–10.19 (NGM). Source: Nexqual, July 25, 2026 at 05:30 UTC.
Key Statistics (as of July 25, 2026 at 05:30 UTC)
| Price | USD 10.19 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 10.19 |
| Open | USD 10.18 |
| Day Range | USD 10.19 – 10.19 |
| 52-Week Range | USD 9.9 – 10.19 |
| Volume | 7 shares |
| Market Cap | $160.76M |
| Exchange | NGM |
Technical Analysis (EMIS)
Nexqual's technical model rates EMIS "STRONG BUY" based on 6 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 05:30 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 71.1 (overbought) |
| vs SMA50 | Above (USD 10.15) |
| MACD | 0.01 (positive) |
Analyst Ratings (EMIS)
Wall Street analysts rate EMIS "None", per Nexqual as of July 25, 2026 at 05:30 UTC.
| Consensus Rating | None |
|---|
Earnings (EMIS)
Source: Nexqual, July 25, 2026 at 05:30 UTC.
Financials & Fundamentals (EMIS)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 11.76 |
| Total Cash | $782,141 |
| Total Debt | $0 |
Source: Nexqual, July 25, 2026 at 05:30 UTC.
Financial Health Score (EMIS)
Nexqual rates Emmis Acquisition Corp.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 05:30 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $782K cash, no debt |
| Cash Flow | Weak — Operating cash flow -$602K |
| Efficiency | Mixed — No data |
Ownership (EMIS)
| Insider Ownership | +13.33% |
|---|---|
| Institutional Ownership | +93.67% |
| Shares Outstanding | 11.94M |
| Float | 11.63M |
| Short % of Float | +0.08% |
Source: Nexqual, July 25, 2026 at 05:30 UTC.
Leadership (EMIS)
Emmis Acquisition Corp. is led by Peter Joseph Goldstein (age 62), Chairman & CEO, per Nexqual as of July 25, 2026 at 05:30 UTC.
| Chairman & CEO | Peter Joseph Goldstein (age 62) |
|---|---|
| CFO & Director | David Lowenstein (age 62) |
Major Backers & Investors (EMIS)
Notable institutional backers of Emmis Acquisition Corp. include Karpus Management, Inc., Glazer Capital LLC, Linden Advisors LP, according to Nexqual as of July 25, 2026 at 05:30 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Karpus Management, Inc. | 25.6% |
| Glazer Capital LLC | 20.38% |
| Linden Advisors LP | 19.57% |
| Shaw D.E. & Co., Inc. | 14.83% |
| Aristeia Capital, LLC | 14.62% |
| Mint Tower Capital Management B.V. | 13.04% |
| Mangrove Partners IM, LLC | 13.04% |
| Radcliffe Capital Management, L.P. | 13.02% |
Source: Nexqual, July 25, 2026 at 05:30 UTC.
From Emmis Acquisition Corp.'s Latest SEC 10-K Filing (filed 2026-03-27)
Key Strengths & Strategy (as disclosed to the SEC)
- Previously, she was the venture capital and startups lead at Amazon Web Services from January 2020 to October 2023 and the Pre-VC startups and ecosystem lead there from January 2020 to August 2023.
- We believe this focus will allow us to leverage the industry knowledge, operational expertise, and extensive networks of our officers, directors, and affiliates of our sponsor.
- Because we are able to complete our initial business combination using our cash, debt or equity securities, or a combination of the foregoing, we have the flexibility to use the most efficient combination that will allow us to tailor the consideration to be paid to the target business to fit its needs and desires.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CASIF | CASI Pharmaceuticals, Inc. | USD 0.13 | ▲ 0% |
| ATRX | Adhera Therapeutics Inc. | USD 0 | ▲ 0% |
| CVAS | CREATIVE VISTAS INC | USD 0 | ▲ 0% |
| GNTA | Genenta Science S.p.A. | USD 1.59 | ▼ 3.05% |
| BIOM | Biomolecular Life Holdings, Inc. | USD 0.46 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 05:30 UTC. This page is informational and not investment advice.